Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric Cancer.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 09 09 2019
revised: 26 09 2019
accepted: 30 09 2019
entrez: 10 11 2019
pubmed: 11 11 2019
medline: 15 11 2019
Statut: ppublish

Résumé

Kita-Kyushu lung cancer antigen-1 (KK-LC-1) is a known cancer/testis antigen. Our group has previously shown KK-LC-1 gene expression in gastric cancer. However, could not be detected the KK-LC-1 protein due to the lack of an appropriate antibody. Here, we assessed our original monoclonal antibody (Kmab34B3) and, using it, assessed the expression of KK-LC-1 in gastric cancer. We evaluated an original monoclonal antibody against KK-LC-1 (Kmab34B3), and used this antibody to compare KK-LC-1 protein expression in tumour and non-tumour stomach cells from gastric cancer patients. Kmab34B3 stained testicular germ cells, and tumour cells in nine out of 11 (82%) specimens. In non-tumorous areas, Kmab34B3 stained 13 out of 29 (45%) pyloric gland specimens. Furthermore, Kmab34B3 also stained intestinal metaplasia positive and negative areas. Kmab34B3 was able to detect KK-LC-1 protein within tumour cells and the pyloric gland where the gene has been shown to be expressed. Therefore, it might be an attractive tool for detecting KK-LC-1 expression in precancerous and cancerous stomach cells.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Kita-Kyushu lung cancer antigen-1 (KK-LC-1) is a known cancer/testis antigen. Our group has previously shown KK-LC-1 gene expression in gastric cancer. However, could not be detected the KK-LC-1 protein due to the lack of an appropriate antibody. Here, we assessed our original monoclonal antibody (Kmab34B3) and, using it, assessed the expression of KK-LC-1 in gastric cancer.
PATIENTS AND METHODS METHODS
We evaluated an original monoclonal antibody against KK-LC-1 (Kmab34B3), and used this antibody to compare KK-LC-1 protein expression in tumour and non-tumour stomach cells from gastric cancer patients.
RESULTS RESULTS
Kmab34B3 stained testicular germ cells, and tumour cells in nine out of 11 (82%) specimens. In non-tumorous areas, Kmab34B3 stained 13 out of 29 (45%) pyloric gland specimens. Furthermore, Kmab34B3 also stained intestinal metaplasia positive and negative areas.
CONCLUSION CONCLUSIONS
Kmab34B3 was able to detect KK-LC-1 protein within tumour cells and the pyloric gland where the gene has been shown to be expressed. Therefore, it might be an attractive tool for detecting KK-LC-1 expression in precancerous and cancerous stomach cells.

Identifiants

pubmed: 31704855
pii: 39/11/6259
doi: 10.21873/anticanres.13835
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antigens, Neoplasm 0
CT83 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6259-6263

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Yoshihito Takahashi (Y)

Department of Surgery, Kitasato University Medical Center, Kitamoto, Japan.
Department of General, Pediatric and Hepatobiliary-Pancreatic Surgery, Kitasato University, Sagamihara, Japan.

Takashi Fukuyama (T)

Department of Biomedical Research, Kitasato University Medical Center, Kitamoto, Japan fukuyam@insti.kitasato-u.ac.jp.

Nobue Futawatari (N)

Department of General and Gastroenterological Surgery, Department of Surgery (Ohashi), Toho University, Tokyo, Japan.

Yoshinobu Ichiki (Y)

Department of General Thoracic Surgery, National Hospital Organization Saitama Hospital, Wako, Japan.

Haruki Ohmiya (H)

Department of Biological Chemistry and Food Sciences, Faculty of Agriculture, Iwate University, Morioka, Japan.

Motohiro Chuman (M)

Department of Surgery, Kitasato University Medical Center, Kitamoto, Japan.
Department of Upper Gastrointestinal Surgery, Kitasato University School of Medicine, Sagamihara, Japan.

Tetsuro Yamashita (T)

Department of Biological Chemistry and Food Sciences, Faculty of Agriculture, Iwate University, Morioka, Japan.

Naoki Hiki (N)

Department of Upper Gastrointestinal Surgery, Kitasato University School of Medicine, Sagamihara, Japan.

Yusuke Kumamoto (Y)

Department of General, Pediatric and Hepatobiliary-Pancreatic Surgery, Kitasato University, Sagamihara, Japan.

Hitoshi Yamazaki (H)

Department of Pathology, Kitasato University Medical Center, Kitamoto, Japan.

Hiroshi Nonoguchi (H)

Department of Internal Medicine, Kitasato University Medical Center, Kitamoto, Japan.

Yatsushi Nishi (Y)

Department of Surgery, Kitasato University Medical Center, Kitamoto, Japan.

Noritada Kobayashi (N)

Department of Biomedical Research, Kitasato University Medical Center, Kitamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH